Stem Cell Therapies for Chronic Kidney Disease Due to Infections
Introduction to Stem Cell Therapies for Chronic Kidney Disease
Chronic kidney disease (MRC) is a global health concern affecting millions of individuals worldwide. Infections are a significant cause of CKD, leading to irreversible kidney damage and often requiring dialysis or kidney transplantation. Stem cell therapies have emerged as a promising approach for treating CKD due to infections, offering the potential for tissue regeneration and functional recovery.
Types of Stem Cells Used in Chronic Kidney Disease Treatment
Various types of stem cells have been investigated for CKD treatment, y compris:
- Cellules souches embryonnaires (ESCs): Derived from early-stage embryos, ESCs have the potential to differentiate into all cell types in the body.
- Cellules souches pluripotentes induites (iPSC): Reprogrammed from adult cells, iPSCs possess similar properties to ESCs.
- Cellules souches mésenchymateuses (MSC): Found in various tissues, MSCs have the ability to differentiate into bone, cartilage, et les cellules graisseuses.
- Renal progenitor cells (RPCs): Derived from the developing kidney, RPCs can differentiate into various kidney cell types.
